TICKERNERD
Menu
ACHCACHCHealthcare · Medical Care Facilities

ACHC Stock Forecast: Acadia Healthcare Co., Inc. Price Predictions for 2026-2027

Last close, 4 Nov 2026
$32
+8.44% on the day

The 14 Wall Street analysts covering Acadia Healthcare Co., Inc. hold a median 12-month price target of $33 — +1.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 51 of 100 as at 3 Nov 2026 — in the upper half.

Market cap
$2.8B
Ticker Nerd rank
51/ 100
Median analyst target
$33
Analysts covering
14
Revenue$865.8M−0.4% y/y
Operating income$87.8M
Net income$12.3M
Free cash flow$123.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+8.8%
1M
+14.5%
YTD
+126.4%
1Y
+55.5%
From 52W high
−9.8%
From 52W low
+175.0%
$12
$36
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ACHC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Acadia Healthcare Co., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Nov 2026
51/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
92
Momentum
75
Revisions
63
Value
59
Volatility
49
Issuance
42
Growth
32
Size
31
Quality
18

Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.

Quality (18): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

ACHC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ACHC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40Jan 26Apr 26Jul 26Oct 26ACHCHigh $41Median $33Low $17

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says14 analysts
8 Buy5 Hold1 Sell
Low $17Median $33High $41

The green dot is the last close — the median target sits +1.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 7 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
23 Sept 2026Leerink PartnersMaintainsMarket Perform$30 → $33
30 July 2026BarclaysMaintainsEqual-Weight—
30 July 2026BarclaysMaintainsEqual-Weight$25 → $32
30 July 2026GuggenheimMaintainsBuy—
30 July 2026GuggenheimMaintainsBuy$38 → $39
20 July 2026GuggenheimMaintainsBuy—
20 July 2026GuggenheimMaintainsBuy$31 → $38
14 July 2026KeybancMaintainsOverweight$30 → $40
14 July 2026KeybancMaintainsOverweight—
14 July 2026TD CowenMaintainsBuy—
14 July 2026TD CowenMaintainsBuy$30 → $36
9 July 2026UBSMaintainsBuy$31 → $39
9 July 2026UBSMaintainsBuy—
3 June 2026JefferiesUpgradeBuy—
4 May 2026GuggenheimMaintainsBuy—
4 May 2026RBC CapitalMaintainsOutperform—
1 May 2026BarclaysMaintainsEqual-Weight—
1 May 2026Cantor FitzgeraldMaintainsNeutral—
28 Apr 2026TD CowenMaintainsBuy—
17 Apr 2026UBSMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

ACHC appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

ACHC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Nov 2026, Acadia Healthcare Co., Inc. returned +55.5% against +12.9% for the S&P 500, dividends included.

ACHC vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120140160180Jan 26Apr 26Jul 26Oct 26ACHCS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ACHC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+2.0%
Analysts raising
1
Analysts cutting
1
Fundamentals

Acadia Healthcare Co., Inc. (ACHC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
20.6×

Cheaper than 36% of US stocks

Price / sales
0.8×

Cheaper than 72% of US stocks

Price / book
1.4×

Cheaper than 58% of US stocks

EV / EBITDA
10.1×

Cheaper than 37% of US stocks

Growth & margins
Revenue growth (YoY)
−0.4%

Higher than 27% of US stocks

Earnings growth (YoY)
−63.7%

Higher than 8% of US stocks

Gross margin
96.5%

Higher than 99% of US stocks

Operating margin
10.1%

Higher than 64% of US stocks

Net margin
−33.4%

Higher than 13% of US stocks

Returns & dividend
Return on equity
−41.4%

Higher than 24% of US stocks

Return on assets
3.6%

Higher than 69% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Acadia Healthcare Co., Inc. (ACHC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Acadia Healthcare Co., Inc. has a market value of $2.8B and an enterprise value of $5.4B.

  • Revenue in the twelve months to 30 June 2026: $3.4B. The latest quarter shrank 0.4% year on year.

  • Net income over the same four quarters: −$1.1B, a −33.3% net margin.

  • Diluted earnings per share, trailing twelve months: $−12.45.

  • Free cash flow in the twelve months to 30 June 2026: −$134.0M, after $344.5M of capital spending.

  • Acadia Healthcare Co., Inc. spent $0.0 on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 90.9M.

  • Trailing P/E: 20.6×; forward P/E: 16.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Acadia Healthcare Co., Inc. employs 25,000 people — $135K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 3 Nov 2026

Data provided by Twelve Data

Peers

ACHC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
ACHCAcadia Healthcare Co., Inc.$2.8B51
GRDNGuardian Pharmacy Services, Inc.$2.6B77
AVAHAveanna Healthcare Holdings, Inc.$2.9B87
MDPediatrix Medical Group, Inc.$2.5B100
SGRYSurgery Partners, Inc.$3.0B41
BKDBrookdale Senior Living, Inc.$2.5B66
ADUSAddus HomeCare Corp.$2.4B95

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Acadia Healthcare Co., Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ACHC news & analysis

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance

Business Wire · 4 Nov 2026positive

Acadia Healthcare reported third-quarter 2026 revenue of $895.3 million, up 5.1% year over year. Same-facility revenue rose 5.2%, with patient days up 1.1% and revenue per patient day up 4.0%; the headline says the company raised full-year 2026 financial guidance.

Why it matters — The revenue growth and higher full-year guidance are updates on Acadia’s operating performance and outlook that ACHC watchers may wish to track.

Acadia Healthcare to Participate in November Investor Conferences

Business Wire · 2 Nov 2026neutral

Acadia Healthcare announced it will participate in two November 2026 investor conferences: the 2026 UBS Global Healthcare Conference on November 9 and the 2026 Stephens Annual Investment Conference on November 18. Its UBS presentation is scheduled to begin at 11:00 a.m. Eastern Time.

Why it matters — The appearances provide ACHC watchers with dates for upcoming opportunities to hear from the company at investor conferences.

GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth

Zacks Investment Research · 29 Oct 2026neutral

The excerpt says GRAIL’s third-quarter earnings were expected to benefit from increased adoption of its Galleri test, expanding digital health partnerships, and growing clinical evidence of cancer detection.

Why it matters — The item concerns GRAIL rather than Acadia Healthcare, so it provides no direct information about ACHC.

Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 13 Oct 2026negative

A PRNewsWire item invites Acadia Healthcare shareholders to contact a firm to discuss their rights and options, at no cost or obligation. The firm says it would handle any matter on a contingent-fee basis.

Why it matters — The item raises a potential shareholder-rights issue involving ACHC insiders, which may be relevant to investors monitoring the company.

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release

Business Wire · 13 Oct 2026neutral

Acadia Healthcare announced it will release third-quarter 2026 results after market close on November 4, 2026. The company will host a conference call for institutional investors and analysts on November 5 at 9:00 a.m. ET, with a live broadcast and archived webcast available through its website.

Why it matters — ACHC watchers can note the dates and access details for the company’s quarterly results and discussion.

FAQ

Frequently asked questions about ACHC stock

What is the ACHC stock price forecast for 2026-2027?

The 14 Wall Street analysts covering Acadia Healthcare Co., Inc. have a median 12-month price target of $33, with estimates ranging from $17 to $41. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ACHC stock a buy right now?

Of the 14 analysts covering Acadia Healthcare Co., Inc., 8 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Acadia Healthcare Co., Inc. 51 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ACHC?

As at 3 Nov 2026, Acadia Healthcare Co., Inc. ranks 51 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).

Will ACHC stock go up?

No one can know that. What the data says: the median 12-month target from 14 analysts implies +1.2% from the last close, and Ticker Nerd's factor model ranks Acadia Healthcare Co., Inc. 51 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ACHC stock forecast for 2030?

No analyst covering Acadia Healthcare Co., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ACHC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $17 to $41 over the next 12 months.

How has ACHC stock performed over the past year?

Acadia Healthcare Co., Inc. returned +55.5% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Acadia Healthcare Co., Inc. do?

Acadia Healthcare Company, Inc. is a behavioral healthcare services provider focused on delivering treatment across a range of clinical settings.

What is the latest news on ACHC?

The most recent item we track (Business Wire, 4 Nov 2026): "Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance". Acadia Healthcare reported third-quarter 2026 revenue of $895.3 million, up 5.1% year over year. Same-facility revenue rose 5.2%, with patient days up 1.1% and revenue per patient day up 4.0%; the headline says the company raised full-year 2026 financial guidance.

Company

About Acadia Healthcare Co., Inc.

Acadia Healthcare Company, Inc. is a behavioral healthcare services provider focused on delivering treatment across a range of clinical settings. The company operates acute inpatient psychiatric facilities, specialty treatment centers, residential treatment programs, comprehensive treatment centers, and outpatient behavioral health services. Its offerings address mental health conditions, substance use disorders, and related recovery needs for patients and communities. Acadia Healthcare serves individuals through a network designed to provide both short-term stabilization and longer-term therapeutic care, making it an important participant in the U.S. behavioral health market. The company’s business is centered on facility-based care, coordinated treatment pathways, and access to specialized services across multiple levels of acuity. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia Healthcare Company, Inc. remains a significant operator in the healthcare services sector.

CEO Ms. Debra K. Osteen · 25,000 employees · United States · https://www.acadiahealthcare.com